Sort
82,697 grants matching “vaccine development”
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
$732,308Yonatan H Grad · Harvard School Of Public Health · R01 · FY2022 · AI
Determinants of retroviral replication in non-native hosts for modeling HIV infection
$732,233Amit Sharma · North Carolina State University Raleigh · R01 · FY2025 · AI
NJMS Clinical Trials Unit: Targeting Pediatric, Adolescent, and Material HIV Infe
$732,230James Oleske · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2010 · AI
mRNA biological pacemaker
$732,221Hee Cheol Cho · Johns Hopkins University · R01 · FY2025 · HL
Targeting tonsillar B cells for the induction of effective mucosal immunity to HIV
$732,179James J Kobie · University Of Alabama At Birmingham · R01 · FY2019 · DE
In-Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol (Poly-ICLC): A phase II Adaptive Multicenter Clinical Study
$732,170Andres Mario Salazar · Oncovir, Inc. · R44 · FY2017 · CA
In-Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol (Poly-ICLC): A phase II Adaptive Multicenter Clinical Study
$732,170Andres Mario Salazar · Oncovir, Inc. · R44 · FY2016 · CA
EPIDEMIOLOGY OF HPV-RELATED SCSC IN TRANSPLANT PATIENTS
$732,085Janet R Daling · Fred Hutchinson Cancer Research Center · P01 · FY2010 · CA
Columbia University-Southern African AIDS International Training/Research Program
$732,050Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2012 · TW
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$732,031Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AR
Enviromental Factors in the Etiology of Autism
$731,918University Of California Davis · P01 · FY2004 · ES
Traineeship in AIDS Prevention Studies
$731,889Susan M. Kegeles · University Of California, San Francisco · T32 · FY2008 · MH
Animal Core
$731,884Saverio Vincent Capuano · University Of Miami School Of Medicine · P01 · FY2012 · AI
Malaria Vaccine: CSP-rEPA
$731,837Louis Miller · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Mechanisms of Enhanced Neutralizing Antibody Responses to Rhinovirus C
$731,761Yury A Bochkov · University Of Wisconsin-Madison · R01 · FY2024 · AI
Targeting neutralizing epitopes in the MPER of HIV Env
$731,756Chinglai Yang · Emory University · R01 · FY2017 · AI
Herpesviruses as Vaccine Vectors for AIDS
$731,734David M Knipe · Harvard Medical School · P01 · FY2010 · AI
Natural Resistance to Mycobacterium Tuberculosis Infection
$731,718W. Henry Henry Boom · Case Western Reserve University · U01 · FY2019 · AI
Traineeship in AIDS Prevention Studies
$731,710University Of California San Francisco · T32 · FY2004 · MH
Targeting RIPK3 in Flu-Associated Lung Injury
$731,691Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2022 · AI
Structure and lineage-based immunogen design scientific research support compone
$731,656Stephen C Harrison · Duke University · UM1 · FY2017 · AI
Structure and Function of Virulence Factors of Bacillus anthracis
$731,644Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Vaccine Production Core
$731,591Thomas N Denny · Duke University · U19 · FY2011 · AI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community
$731,587Robert H Gilman · Johns Hopkins University · R01 · FY2015 · AI
Integrated Platform for the Discovery of Antibacterial
$731,560Suzanne L. Walker · Harvard Medical School · U19 · FY2015 · AI